Spire Biomedical raises $16 million from catheter licence
This article was originally published in Clinica
Executive Summary
Spire has sold an exclusive patent licence to a haemodialysis catheter marketed by its Spire Biomedical subsidiary to CR Bard subsidiary Bard Access Systems for $16m.